DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C1306459 | Primary malignant neoplasm | HAS2 | 3037 | hyaluronan synthase 2 | Q92819 |
C1306459 | Primary malignant neoplasm | C1GALT1C1 | 29071 | C1GALT1 specific chaperone 1 | Q96EU7 |
C1306459 | Primary malignant neoplasm | POMT2 | 29954 | protein O-mannosyltransferase 2 | Q9UKY4 |
C1306459 | Primary malignant neoplasm | CHPF2 | 54480 | chondroitin polymerizing factor 2 | Q9P2E5 |
C1306459 | Primary malignant neoplasm | PIGA | 5277 | phosphatidylinositol glycan anchor biosynthesis class A | P37287 |
C1306459 | Primary malignant neoplasm | MGAT3 | 4248 | beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase | Q09327 |
C1306459 | Primary malignant neoplasm | GALNT7 | 51809 | polypeptide N-acetylgalactosaminyltransferase 7 | Q86SF2 |
C1306459 | Primary malignant neoplasm | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C1306459 | Primary malignant neoplasm | PIGX | 54965 | phosphatidylinositol glycan anchor biosynthesis class X | Q8TBF5 |
C1306459 | Primary malignant neoplasm | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C1306459 | Primary malignant neoplasm | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C1306459 | Primary malignant neoplasm | MGAT1 | 4245 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | P26572 |
C1306459 | Primary malignant neoplasm | ST8SIA3 | 51046 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | O43173 |
C1306459 | Primary malignant neoplasm | B4GALNT4 | 338707 | beta-1,4-N-acetyl-galactosaminyltransferase 4 | Q76KP1 |
C1306459 | Primary malignant neoplasm | CHST15 | 51363 | carbohydrate sulfotransferase 15 | Q7LFX5 |
C1306459 | Primary malignant neoplasm | XYLT2 | 64132 | xylosyltransferase 2 | Q9H1B5 |
C1306459 | Primary malignant neoplasm | NDST4 | 64579 | N-deacetylase and N-sulfotransferase 4 | Q9H3R1 |
C1306459 | Primary malignant neoplasm | ST6GAL1 | 6480 | ST6 beta-galactoside alpha-2,6-sialyltransferase 1 | P15907 |
C1306459 | Primary malignant neoplasm | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C1306459 | Primary malignant neoplasm | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C1306459 | Primary malignant neoplasm | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C1306459 | Primary malignant neoplasm | POGLUT1 | 56983 | protein O-glucosyltransferase 1 | Q8NBL1 |
C1306459 | Primary malignant neoplasm | C1GALT1 | 56913 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | Q9NS00 |
C1306459 | Primary malignant neoplasm | GALNT11 | 63917 | polypeptide N-acetylgalactosaminyltransferase 11 | Q8NCW6 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024